Recombinant CD4 (Tregalizumab Biosimilar) antibody

Catalog No. ABIN7675931

The Human Monoclonal anti-CD4 (Tregalizumab Biosimilar) antibody (ABIN7675931) specifically detects CD4 (Tregalizumab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant CD4 (Tregalizumab Biosimilar) antibody (ABIN7675931)

Target: CD4 (Tregalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD4 (Tregalizumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD4 (Tregalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD4 Reference Antibody (tregalizumab)

Characteristics: Anti-CD4 Reference Antibody (tregalizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD4 (Tregalizumab Biosimilar)

Target: CD4 (Tregalizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P01730